The abstract is read at the publisher; the summary is JClub's.
In England, initiation of oral second-generation antipsychotics in adults with severe mental illness is linked to a rapid HbA1c rise of 0·12 mmol/mol per week during the first 90 days.
- Why it matters: Early cardiometabolic risk after starting antipsychotics is unclear, including when glycaemic change occurs and whether it tracks weight gain, limiting timely monitoring and prevention.
- What they did: Using individual-level interrupted time-series mixed models with linear splines on Clinical Practice Research Datalink Aurum EHR data (Jan 1, 2000–June 7, 2023), HbA1c and weight were modeled before treatment, 0–90 days after, and 91 days–2 years, stratified by sex, drug, and baseline glycaemic status.
- The result: HbA1c increased at 0·01 mmol/mol per week pre-treatment, then returned to 0·01 mmol/mol per week from day 91 to 2 years; this supports monitoring both outcomes at baseline and 12 weeks, then risk-stratified follow-up.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.